<?xml version="1.0" encoding="UTF-8"?>
<p id="par0010">Traditional Chinese medicine (TCM) has indeed brought benefits for COVID-19 patients in China. Besides treatments with the 
 <italic>Qingfei Paidu</italic> Decoction (QPD) and 
 <italic>Qingjin Jianghuo</italic> Decoction (QJD) mentioned in the previous article [
 <xref rid="bib0005" ref-type="bibr">1</xref>], many other TCM prescriptions used for COVID-19 patients in China have been reported to be effective, including 
 <italic>Lianhua Qingwen</italic> Granule (LQG), 
 <italic>Toujie Quwen</italic> granules (TQG), and 
 <italic>Reyanning</italic> Mixture (RYM). Most of the published cases referred patients using TCM on the basis of chemical drug therapy. For example, Cheng Dezhong et al. [
 <xref rid="bib0010" ref-type="bibr">2</xref>] reported a study demonstrating the therapeutic efficacy of LQG combined with chemical drug therapy treating COVID-19 patients. For a 7-day treatment, the control group was given nutritional support, symptomatic treatment, antiviral and antibacterial drugs, and the treatment group was treated with LQG combined with nutritional support, and treatment with antiviral and antibacterial drugs. After 7 days, the disappearance rates of main symptoms (fever, fatigue, cough) in the treatment group were 83.7 % (fever), 61.3 % (fatigue) and 62.2 % (cough), respectively, whereas in the control group they were 61.0 %, 34.3 % and 35.9 %, respectively; the clinical effective rate (eliminating main symptoms) of the treatment group was 86.3 % in comparison with the control group in which it was 68.6 %.
</p>
